[ad_1]
NEW YORK, March 30, 2019 (GLOBE NEWSWIRE) – Rosen Law Firm, an investor rights law firm, announces the filing of the first clbad action lawsuit on behalf of purchasers of American Renal Associates Holdings, Inc. (NYSE). : ARA) from August 10, 2016 to March 27, 2019 inclusive (the "Target Period"). The lawsuit seeks damages for US Renal investors under federal securities laws.
To join the clbad action against American Renal, go to https://www.rosenlegal.com/cases-register-1533.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or by email [email protected] or [email protected] for more information on the clbad action.
NO CATEGORY HAS BEEN CERTIFIED IN THE ACTION ABOVE. UNTIL A CATEGORY IS CERTIFIED, YOU ARE NOT REPRESENTED BY AN ADVICE UNLESS YOU KEEP IT. YOU CAN KEEP A CONSIDERATION OF YOUR CHOICE. You can also stay in the absent clbad and do nothing at that time. THE CAPACITY OF AN INVESTOR TO PARTICIPATE IN ANY POTENTIAL RECOVERY WILL NOT BE DEPENDENT ON THE FUNCTIONING OF A PLAINTIFF.
According to the prosecution, the defendants made false and / or misleading statements and / or failed to disclose that: (1) problems with the American Renal accounting process regarding revenue recognition, recoveries and other matters; related issues would give rise to the creation of a US Securities and Exchange Commission ("SEC") investigation of the same, and a thorough regulatory review by the SEC; (2) The financial statements of American Renal for fiscal years 2014, 2015, 2016 and 2017 contained in its annual reports for the years ended December 31, 2016 and 2017 and its consolidated financial statements summarized in the 2016 quarterly reports to 2018 were false and could not be relied on; (3) American Renal had significant weaknesses in its internal control over financial reporting; and (4) as a result, the public statements of the accused were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims that the investors have suffered damages.
A clbad action has already been filed. If you wish to serve as principal applicant, you must file a motion with the Court no later than May 28, 2019. A principal applicant is a representative party who acts on behalf of other members of the group in the direction of the principal applicant. dispute. If you wish to join the litigation, go to https://www.rosenlegal.com/cases-register-1533.html or to discuss your rights or interests in this clbad action, please contact Phillip Kim or Zachary Halper of the law firm Rosen Law Firm toll-free at 866-767-3653 or by email at the following address: [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen's law firm represents investors from around the world and focuses its practice on clbad actions in securities and derivative litigation by shareholders. Rosen's law firm has been ranked # 1 by ISS Securities Clbad Action Services for the number of clbad action lawsuits filed in 2017. The firm has been in the top 3 every year since 2013.
——————————-
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The law firm Rosen, P.A.
275 Madison Avenue, 34th Ground
New York, NY 10016
Tel .: (212) 686-1060
Toll free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
[ad_2]
Source link
